Pfizer, Moderna Apply for EUA for COVID Shots for Infants, FDA to Decide Quickly

On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, […]
Prevalence of Autism Up Around the World

A new report published in the journal Autism Research found the prevalence of autism spectrum disorder (ASD) has grown to about 100 in 10,000 children—up from 62 in 10,000 children a decade ago. The figure is based on a systematic review of 71 epidemiological studies providing 99 ASD prevalence estimates from 34 countries, primarily the […]
Childhood Obesity Epidemic Made Worse by Social Distancing Policies

The mysterious outbreak of hepatitis (inflammation of the liver) in children in the United States has now grown to 109 cases, including five deaths. The U.S. Centers for Disease Control and Prevention (CDC) is investigating these cases that have been reported in 25 states and territories during the past seven months. The World Health Organization […]
Global Hepatitis Outbreak in Children May Be Linked to Social Distancing Policies

The current mysterious outbreak of acute hepatitis (inflammation of the liver) in children in the United States, specifically in Alabama, could be caused by an adenovirus infection that children are more susceptible to because of COVID-19 pandemic-related social distancing policies, according to a report released by the U.S. Centers for Disease Control and Prevention (CDC) […]
Moderna Recalls 764,900 Doses of Spikevax Due to Contamination Problem

Moderna, Inc., developer of the experimental messenger RNA (mRNA) mRNA-1273, or “Spikevax,” biologic, has recalled 764,900 doses in lot #000190A of the product from the European market. On Apr. 8, 2022, the company said that the doses, manufactured under contract to Moderna by Spanish pharmaceutical company ROVI Pharma Industrial Services, SAU, are being pulled out […]
Autism Rate at 1 in 14 Students in NJ’s Toms River District: A ‘Harbinger’ of Things to Come

Based on findings by an autism spectrum disorders (ASD) monitoring system at Rutgers University known as the New Jersey Autism Study (NJAS), the autism rate for four-year-old children in New Jersey is estimated at 1 in 35 children—the highest of any state in the United States. This figure, however, is at least eight years old. […]